Jpmorgan Chase & CO Eterna Therapeutics Inc. Commo Transaction History

Jpmorgan Chase & CO

  • $1.23 Trillion
  • Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Eterna Therapeutics Inc. Commo stock. As of the latest transaction made, Jpmorgan Chase & CO holds 59 shares of ERNA stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
59
Previous 14 321.43%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
N/A
45 Added 321.43%
59 $0
Q4 2022

Feb 13, 2023
BUY
N/A
14 New
14 $0

Others Institutions Holding ERNA

# of Institutions
24
Shares Held
994K
Call Options Held
0
Put Options Held
0
View Full List

About ETERNA THERAPEUTICS INC. COMMO

ERNA Quotes by TradingView
  • Ticker ERNA
More about ERNA
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email